Targeting pain and inflammation by peripherally acting opioids

Frontiers in Pharmacology

Volumn 4 SEP, Issue , 2013, Pages

  Stein, Christoph ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Analgesia; Inflammation; Opioid peptide; Opioid receptor; Pain

Indexed keywords

ASIMADOLINE; BETA ENDORPHIN; CD31 ANTIGEN; CORTICOSTEROID DERIVATIVE; CR 845; DELTA OPIATE RECEPTOR AGONIST; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ENKEPHALIN; FE 200665; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; INTERCELLULAR ADHESION MOLECULE 1; JANUS KINASE INHIBITOR; KAPPA OPIATE RECEPTOR AGONIST; LOCAL ANESTHETIC AGENT; LOPERAMIDE; MORPHINE; MORPHINE 6 GLUCURONIDE; NALFURAFINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE AGONIST; OPIATE DERIVATIVE; OPIATE PEPTIDE; OPIATE RECEPTOR; PROENKEPHALIN; PROOPIOMELANOCORTIN; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TYROSYL DEXTRO ARGINYLPHENYLALANYLLYSINAMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLOID RECEPTOR 1;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; APNEA; BLEEDING; CEREBROVASCULAR ACCIDENT; CHRONIC PAIN; COGNITIVE DEFECT; CORNEA DISEASE; DRUG BINDING SITE; DRUG CARCINOGENICITY; DRUG RECEPTOR BINDING; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; INFECTION; INFLAMMATORY CELL; INFLAMMATORY PAIN; NEUROPATHIC PAIN; NONHUMAN; NOTE; PERIPHERAL NERVE INJURY; POSTOPERATIVE PAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SKIN ULCER; THROMBOEMBOLISM; TOOTH PAIN; ULCER; VISCERAL PAIN;

EID: 84885338409     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2013.00123     Document Type: Note

References (32)

1. Binning, A. R., Przesmycki, K., Sowinski, P., Morrison, L. M., Smith, T. W., Marcus, P., et al. (2011). A randomised controlled trial on the efficacy and side-effect profile (nausea/vomiting/sedation) of morphine-6-glucuronide versus morphine for post-operative pain relief after major abdominal surgery. Eur. J. Pain 15, 402-408. doi:10.1016/j.ejpain.2010.09.007.
2. Busch-Dienstfertig, M., Labuz, D., Wolfram, T., Vogel, N. N., and Stein, C. (2012). JAK-STAT1/3-induced expression of signal sequence-encoding proopiomelanocortin mRNA in lymphocytes reduces inflammatory pain in rats. Mol. Pain 8, 83. doi:10.1186/1744-8069-8-83.
3. Cayla, C., Labuz, D., Machelska, H., Bader, M., Schäfer, M., and Stein, C. (2012). Impaired nociception and peripheral opioid antinociception in mice lacking both kinin B1 and B2 receptors. Anesthesiology 116, 448-457. doi:10.1097/ALN.0b013e318242b2ea.
4. Dahan, A., van Dorp, E., Smith, T., and Yassen, A. (2008). Morphine-6-glucuronide (M6G) for postoperative pain relief. Eur. J. Pain 12, 403-411. doi:10.1016/j.ejpain.2007.07.009.
5. Endres-Becker, J., Heppenstall, P. A., Mousa, S. A., Labuz, D., Oksche, A., Schäfer, M., et al. (2007). Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain. Mol. Pharmacol. 71, 12-18. doi:10.1124/mol.106.026740.
6. Farley, P. (2011). Should topical opioid analgesics be regarded as effective and safe when applied to chronic cutaneous lesions. J. Pharm. Pharmacol. 63, 747-756. doi:10.1111/j.2042-7158.2011.01252.x.
7. Hua, S., and Cabot, P. J. (2013). Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions:a potential novel treatment of acute and chronic pain condition. Pain Physician 16, E199-E216.
8. Kalso, E., Smith, L., McQuay, H. J., and Moore, R. A. (2002). No pain, no gain:clinical excellence and scientific rigour-lessons learned from IA morphine. Pain 98, 269-275. doi:10.1016/S0304-3959(02)00019-2.
9. Labuz, D., Schmidt, Y., Schreiter, A., Rittner, H. L., Mousa, S. A., and Machelska, H. (2009). Immune cell-derived opioids protect against neuropathic pain in mice. J. Clin. Invest. 119, 278-286. doi:10.1172/JCI36246.
10. Moshourab, R., and Stein, C. (2012). Fentanyl decreases discharges of C and A nociceptors to suprathreshold mechanical stimulation in chronic inflammation. J. Neurophysiol. 108, 2827-2836. doi:10.1152/jn.00082.2012.
11. Nockemann, D., Rouault, M., Labuz, D., Hublitz, P., McKnelly, K., Reis, F. C., et al. (2013). The K channel GIRK2 is both necessary and sufficient for peripheral opioid-mediated analgesia. EMBO Mol. Med. 5, 1263-1277. doi:10.1002/emmm.201201980.
12. Patwardhan, A. M., Berg, K. A., Akopain, A. N., Jeske, N. A., Gamper, N., Clarke, W. P., et al. (2005). Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors. J. Neurosci. 25, 8825-8832. doi:10.1523/JNEUROSCI.0160-05.2005.
13. Pettinger, L., Gigout, S., Linley, J. E., and Gamper, N. (2013). Bradykinin controls pool size of sensory neurons expressing functional delta-opioid receptors. J. Neurosci. 33, 10762-10771. doi:10.1523/JNEUROSCI.0123-13.2013.
14. Picard, P. R., Tramer, M. R., McQuay, H. J., and Moore, R. A. (1997). Analgesic efficacy of peripheral opioids (all except intra-articular):a qualitative systematic review of randomised controlled trials. Pain 72, 309-318. doi:10.1016/S0304-3959(97)00040-7.
15. Raja, S. N. (2012). Modulating pain in the periphery:gene-based therapies to enhance peripheral opioid analgesia:bonica lecture, ASRA (2010). Reg. Anesth. Pain Med. 37, 210-214. doi:10.1097/AAP.0b013e31823b145f.
16. Rittner, H. L., Amasheh, S., Moshourab, R., Hackel, D., Yamdeu, R. S., Mousa, S. A., et al. (2012). Modulation of tight junction proteins in the perineurium to facilitate peripheral opioid analgesia. Anesthesiology 116, 1323-1334. doi:10.1097/ALN.0b013e318256eeeb.
17. Rittner, H. L., Hackel, D., Voigt, P., Mousa, S., Stolz, A., Labuz, D., et al. (2009). Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils. PLoS Pathog. 5:e1000362. doi:10.1371/journal.ppat.1000362.
18. Roques, B. P., Fournie-Zaluski, M. C., and Wurm, M. (2012). Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain. Nat. Rev. Drug Discov. 11, 292-310. doi:10.1038/nrd3673.
19. Sawynok, J. (2003). Topical and peripherally acting analgesics. Pharmacol. Rev. 55, 1-20. doi:10.1124/pr.55.1.1.
20. Schreiter, A., Gore, C., Labuz, D., Fournie-Zaluski, M. C., Roques, B. P., Stein, C., et al. (2012). Pain inhibition by blocking leukocytic and neuronal opioid peptidases in peripheral inflamed tissue. FASEB J. 26, 5161-5171. doi:10.1096/fj.12-208678.
21. Spahn, V., Fischer, O., Endres-Becker, J., Schäfer, M., Stein, C., and Zöllner, C. (2013). Opioid withdrawal increases transient receptor potential vanilloid 1 activity in a protein kinase A-dependent manner. Pain 154, 598-608. doi:10.1016/j.pain.2012.12.026.
22. Stein, C. (1993). Peripheral mechanisms of opioid analgesia. Anesth. Analg. 76, 182-191. doi:10.1213/00000539-199301000-00031.
23. Stein, C. (2013). Towards safer and more effective analgesia. Vet. J. 196, 6-7. doi:10.1016/j.tvjl.2012.09.013.
24. Stein, C., Hassan, A. H. S., Lehrberger, K., Giefing, J., and Yassouridis, A. (1993). Local analgesic effect of endogenous opioid peptides. Lancet 342, 321-324. doi:10.1016/0140-6736(93)91471-W.
25. Stein, C., and Küchler, S. (2012). Non-analgesic effects of opioids:peripheral opioid effects on inflammation and wound healing. Curr. Pharm. Des. 18, 6053-6069. doi:10.2174/138161212803582513.
26. Stein, C., and Küchler, S. (2013). Targeting inflammation and wound healing by opioids. Trends Pharmacol. Sci. 34, 303-312. doi:10.1016/j.tips.2013.03.006.
27. Stein, C., and Machelska, H. (2011). Modulation of peripheral sensory neurons by the immune system:implications for pain therapy. Pharmacol. Rev. 63, 860-881. doi:10.1124/pr.110.003145.
28. Stein, C., Schäfer, M., and Machelska, H. (2003). Attacking pain at its source:new perspectives on opioids. Nat. Med. 9, 1003-1008. doi:10.1038/nm908.
29. Trelle, S., Reichenbach, S., Wandel, S., Hildebrand, P., Tschannen, B., Villiger, P. M., et al. (2011). Cardiovascular safety of non-steroidal anti-inflammatory drugs:network meta-analysis. BMJ 342:c7086. doi:10.1136/bmj.c7086.
30. Vadivelu, N., Mitra, S., and Hines, R. L. (2011). Peripheral opioid receptor agonists for analgesia:a comprehensive review. J. Opioid Manag. 7, 55-68. doi:10.5055/jom.2011.0049.
31. Vetter, I., Cheng, W., Peiris, M., Wyse, B. D., Roberts-Thomson, S. J., Zheng, J., et al. (2008). Rapid, opioid-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization. J. Biol. Chem. 283, 19540-19550. doi:10.1074/jbc. M707865200.
32. Zöllner, C., Mousa, S. A., Fischer, O., Rittner, H. L., Shaqura, M., Brack, A., et al. (2008). Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. J. Clin. Invest. 118, 1065-1073. doi:10.1172/JCI25911.